Health in Oman 325 indicators covering health for Oman. IndicatorLatest Year10-yr change Rank Population ages 75-79, male 12,526 2025 up 29.9% 144th Population ages 80 and above, female 14,362 2025 up 37.3% 143rd Population ages 80 and above, male 11,135 2025 up 24.3% 136th Prevalence of overweight, weight for height, female 8.2% 2024 up 164.5% 47th Prevalence of overweight, weight for height, male 9.3% 2024 up 165.7% 48th Prevalence of overweight, weight for height 8.8% 2024 up 166.7% 47th Prevalence of stunting, height for age, female 11.4% 2024 up 14.0% 80th Prevalence of stunting, height for age, male 14.4% 2024 up 12.5% 75th Prevalence of stunting, height for age 12.9% 2024 up 13.2% 78th Hospital beds 0.99 per 1,000 people 2023 down 21.4% 140th Tuberculosis death rate 0.36 per 100,000 people 2024 down 16.3% 157th Incidence of tuberculosis 11 per 100,000 people 2024 down 15.4% 144th People using at least basic drinking water services, urban 94.7% 2024 up 1.1% 135th People using at least basic sanitation services, urban 99.3% 2024 unchanged 35th People practicing open defecation, urban 0.0% 2024 — 95th People using at least basic drinking water services, rural 76.3% 2024 up 3.1% 127th People using at least basic sanitation services, rural 99.3% 2024 up 1.4% 24th People using at least basic drinking water services 92.7% 2024 up 3.2% 143rd People using safely managed drinking water services 91.1% 2024 up 3.4% 58th People practicing open defecation, rural 0.0% 2024 — 103rd People using at least basic sanitation services 99.3% 2024 up 0.3% 42nd Tuberculosis case detection rate 69.0% 2024 up 3.0% 141st People practicing open defecation 0.0% 2024 — 129th Current health expenditure 3.5% 2023 up 39.3% 168th Current health expenditure per capita 732.04 current US$ 2023 up 24.6% 75th Out-of-pocket expenditure 6.3% 2023 down 9.5% 184th Out-of-pocket expenditure per capita 46.2 current US$ 2023 up 12.8% 128th Domestic general government health expenditure 85.3% 2023 down 2.5% 8th Domestic general government health expenditure per capita, PPP 1,233 current international $ 2023 up 19.5% 64th Domestic private health expenditure 14.7% 2023 up 17.7% 172nd Healthcare spending vs. GDP per capita 1,444 current international $ 2023 up 22.6% 79th Domestic private health expenditure per capita 107.32 current US$ 2023 up 46.6% 111th Immunization, Hib3 99.0% 2024 unchanged 1st Child mortality vs. average years of schooling for women 1.03 deaths per 100 live births 2024 down 8.1% 121st Reported cases of measles 13 Cases 2024 — 113th Child mortality by income level of country 1.03 deaths per 100 live births 2024 down 8.1% 121st Number of infant deaths 720 2024 down 4.0% 114th Number of under-five deaths 884 2024 down 1.0% 114th Number of neonatal deaths 512 2024 up 8.7% 112th Child mortality vs. health spending 1.03 deaths per 100 live births 2024 down 8.1% 121st Share of one-year-olds vaccinated against measles 99.0% 2024 unchanged 1st Adolescent fertility rate 5.65 births per 1,000 women ages 15-19 2024 down 63.2% 178th Sex ratio at birth 1.04 male births per female births 2024 down 0.2% 138th Domestic general government health expenditure 10.8% 2023 up 94.3% 87th External health expenditure 0.0% 2023 — 150th External health expenditure per capita 0 current US$ 2023 — 150th External health expenditure per capita, PPP 0 current international $ 2023 — 150th Prevalence of anemia among women of reproductive age 34.4% 2023 up 2.1% 47th Prevalence of anemia among non-pregnant women 34.4% 2023 up 2.1% 46th Prevalence of anemia among pregnant women 35.6% 2023 up 1.4% 51st Stillbirth rate 5.1 per 1,000 total births 2023 down 10.5% 128th Children orphaned by HIV/AIDS 730 2024 up 5.8% 99th Life expectancy vs. health spending 80.03 years 2023 up 1.8% 57th Prevalence of undernourishment 5.9% 2023 down 14.5% 78th Immunization, measles second dose 99.0% 2024 unchanged 1st Antiretroviral therapy coverage 68.0% 2024 up 88.9% 82nd Tuberculosis treatment success rate 39.0% 2023 down 59.4% 192nd Prevalence of hypertension, female 38.8% 2019 down 7.4% 93rd Prevalence of hypertension, male 48.3% 2019 down 2.4% 22nd Prevalence of hypertension 45.6% 2019 down 3.0% 21st ← Previous Page 4 of 6 Next →